PrasugrelWIVIOTT, Stephen D; ANTMAN, Elliott M; BRAUNWALD, Eugene et al.Circulation (New York, N.Y.). 2010, Vol 122, Num 4, pp 394-403, issn 0009-7322, 10 p.Article

Clopidogrel response variability, resistance, or both?WIVIOTT, Stephen D.The American journal of cardiology. 2006, Vol 98, Num 10, issn 0002-9149, 18N-24N, SUPArticle

When Stable Becomes Unstable: The Perils of Impersonal MedicineDESAI, R; BECKMAN, Joshua; WIVIOTT, Stephen D et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 3, pp 335-341, issn 0009-7322, 7 p.Article

Antiplatelet agents make a comeback in ST-elevation myocardial infarctionWIVIOTT, Stephen D; DE LEMOS, James A.The American heart journal. 2007, Vol 154, Num 4, pp 603-606, issn 0002-8703, 4 p.Article

Clopidogrel resistance: A new chapter in a fast-moving storyWIVIOTT, Stephen D; ANTMAN, Elliott M.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 3064-3067, issn 0009-7322, 4 p.Article

Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes: From the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy—Thrombolysis In Myocardial Infarction 22) Trial : PREVENTION/OUTCOMESMURPHY, Sabina A; CANNON, Christopher P; WIVIOTT, Stephen D et al.Journal of the American College of Cardiology. 2009, Vol 54, Num 25, pp 2358-2362, issn 0735-1097, 5 p.Article

Coronary CT Angiography versus Standard Evaluation in Acute Chest PainHOFFMANN, Udo; TRUONG, Quynh A; KALANJIAN, Shant et al.The New England journal of medicine. 2012, Vol 367, Num 4, pp 299-308, issn 0028-4793, 10 p.Article

Short-Term Outcomes of Acute Myocardial Infarction in Patients With Acute Kidney Injury: A Report From the National Cardiovascular Data RegistryFOX, Caroline S; MUNTNER, Paul; CHEN, Anita Y et al.Circulation (New York, N.Y.). 2012, Vol 125, Num 3, pp 497-504, issn 0009-7322, 8 p.Article

Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non―ST-segment elevation acute coronary syndromes with a planned early invasive strategyGABRIEL STEG, Philippe; MEHTA, Shamir R; POLLACK, Charles V et al.The American heart journal. 2012, Vol 164, Num 6, pp 817-824, issn 0002-8703, 8 p.Article

Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: Observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22)WILSON, Sean R; SABATINE, Marc S; WIVIOTT, Stephen D et al.The American heart journal. 2011, Vol 161, Num 6, pp 1147-1155, issn 0002-8703, 9 p.Article

Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease: The Lessons From Antagonizing the Cellular Effect of Thrombin-Coronary Artery Disease TrialWIVIOTT, Stephen D; FLATHER, Marcus D; ANGIOLILLO, Dominick J et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 17, pp 1854-1863, issn 0009-7322, 10 p.Article

Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes: The Lessons From Antagonizing the Cellular Effects of Thrombin-Acute Coronary Syndromes TrialO'DONOGHUE, Michelle L; BHATT, Deepak L; GUETTA, Victor et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 17, pp 1843-1853, issn 0009-7322, 11 p.Article

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38) : double-blind, randomised controlled trialMONTALESCOT, Gilles; WIVIOTT, Stephen D; BRAUNWALD, Eugene et al.Lancet (British edition). 2009, Vol 373, Num 9665, pp 723-731, issn 0140-6736, 9 p.Article

Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the aggrastat to zocor and pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 trials)MURPHY, Sabina A; CANNON, Christopher P; WIVIOTT, Stephen D et al.The American journal of cardiology. 2007, Vol 100, Num 7, pp 1047-1051, issn 0002-9149, 5 p.Article

Prasugrel versus clopidogrel in patients with acute coronary syndromesWIVIOTT, Stephen D; BRAUNWALD, Eugene; RIESMEYER, Jeffrey et al.The New England journal of medicine. 2007, Vol 357, Num 20, pp 2001-2015, issn 0028-4793, 15 p.Article

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y₁₂ antagonist, with clopidogrel in percutaneous coronary intervention : Results of the joint utilization of medications to block platelets optimally (JUMBO)-TIMI 26 trialWIVIOTT, Stephen D; ANTMAN, Elliott M; BRAUNWALD, Eugene et al.Circulation (New York, N.Y.). 2005, Vol 111, Num 25, pp 3366-3373, issn 0009-7322, 8 p.Article

Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13 307 patients in five TIMI trialsGIBSON, C. Michael; DUMAINE, Raphaelle L; GELFAND, Eli V et al.European heart journal. 2004, Vol 25, Num 22, pp 1998-2005, issn 0195-668X, 8 p.Article

Edoxaban versus Warfarin in Patients with Atrial FibrillationGIUGLIANO, Robert P; RUFF, Christian T; RUZYLLO, Witold et al.The New England journal of medicine. 2013, Vol 369, Num 22, pp 2093-2104, issn 0028-4793, 12 p.Article

American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation Universal Definition of Myocardial Infarction Classification System and the Risk of Cardiovascular Death: Observations From the TRITON-TIMI 38 Trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38)BONACA, Marc P; WIVIOTT, Stephen D; BRAUNWALD, Eugene et al.Circulation (New York, N.Y.). 2012, Vol 125, Num 4, pp 577-583, issn 0009-7322, 7 p.Article

Hospital Length of Stay in Patients with Non-ST-segment Elevation Myocardial InfarctionVAVALLE, John P; LOPES, Renato D; GRANGER, Christopher B et al.The American journal of medicine. 2012, Vol 125, Num 11, pp 1085-1094, issn 0002-9343, 10 p.Article

Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research ConsortiumMEHRAN, Roxana; RAO, Sunil V; SEREBRUANY, Victor et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 23, pp 2736-2747, issn 0009-7322, 12 p.Article

Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapyHOCHHOLZER, Willibald; TRENK, Dietmar; SABATINE, Marc S et al.The American heart journal. 2011, Vol 162, Num 3, pp 518-526, issn 0002-8703, 9 p.Article

Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality: Insights From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel—Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38)HOCHHOLZER, Willibald; WIVIOTT, Stephen D; ANTMAN, Elliott M et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 23, pp 2681-2689, issn 0009-7322, 9 p.Article

Streptokinase and Enoxaparin as an Alternative to Fibrin-Specific Lytic-Based Regimens: An ExTRACT-TIMI 25 AnalysisGIRALDEZ, Roberto R; WIVIOTT, Stephen D; NICOLAU, Jose C et al.Drugs (Basel). 2009, Vol 69, Num 11, pp 1433-1443, issn 0012-6667, 11 p.Article

The Efficacy and Safety of Prasugrel With and Without a Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention: A TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) AnalysisO'DONOGHUE, Michelle; ANTMAN, Elliott M; WIVIOTT, Stephen D et al.Journal of the American College of Cardiology. 2009, Vol 54, Num 8, pp 678-685, issn 0735-1097, 8 p.Article